Aevice Well being has introduced that its flagship medical machine, a wearable stethoscope for respiratory well being monitoring, has been accepted by Singapore’s Well being Sciences Authority.
The AI-powered wearable stethoscope AeviceMD, which is worn on the chest, constantly detects and information irregular breath sounds, comparable to wheezing, and screens very important indicators together with coronary heart fee and respiratory fee.
Based mostly on a press assertion, the monitoring machine system has been accepted to be used in folks aged three and above and in each medical and residential settings.
WHY IT MATTERS
Singapore has one of many highest bronchial asthma and COPD prevalences on this planet. Bronchial asthma impacts round 5% of adults and 20% of kids within the nation whereas COPD is likely one of the 10 main illness killers.
With its distant well being monitoring expertise, Aevice Well being goals to assist scale back ED displays and readmissions amongst sufferers coping with these continual respiratory illnesses. By offering well being professionals with an outline of a affected person’s lung well being, AeviceMD helps the early detection of potential exacerbations.
Based on the corporate, it should use its HSA approval as a springboard to broaden the attain of its expertise to populations with excessive circumstances of respiratory illnesses.
„We’re excited to leverage Singapore’s strategic presence in Asia as a medical hub to deliver this novel expertise into new markets the place there’s a excessive prevalence of respiratory illnesses,“ Aevice Well being CEO Adrian Ang shared.
THE LARGER TREND
The market approval comes two years since Aevice Well being first performed a medical trial of AeviceMD with the Nationwide College Well being System to research its use circumstances in paediatric sufferers with respiration difficulties.
Apart from Singapore, the machine has additionally been launched in Japan utilizing the $2 million proceeds from its pre-Collection A funding spherical in 2021.
